(Q40110840)

17 September 2017

title

Single-chain Fv immunoliposomes for the targeting of fibroblast activation protein-expressing tumor stromal cells (English)

1 reference

17 September 2017

Patrick Baum

1

1 reference

17 September 2017

Dafne Müller

series ordinal

2

1 reference

17 September 2017

Ronny Rüger

series ordinal

3

1 reference

17 September 2017

Roland E Kontermann

series ordinal

4

1 reference

17 September 2017

publication date

1 July 2007

1 reference

Journal of Drug Targeting

17 September 2017

published in

1 reference

17 September 2017

volume

15

1 reference

17 September 2017

issue

6

1 reference

17 September 2017

page(s)

399-406

1 reference

Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein alpha

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10611860701453034

The tumour microenvironment as a target for chemoprevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860701453034

Targeted bioactivity of membrane-anchored TNF by an antibody-derived TNF fusion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860701453034

Stromal fibroblasts in cancer initiation and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860701453034

Role of tissue stroma in cancer cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860701453034

Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860701453034

Restoration of membrane TNF-like activity by cell surface targeting and matrix metalloproteinase-mediated processing of a TNF prodrug

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860701453034

Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860701453034

21 January 2018

Fibroblasts in cancer

1 reference

https://api.crossref.org/works/10.1080%2F10611860701453034

Fibroblast activation protein-alpha and dipeptidyl peptidase IV (CD26): cell-surface proteases that activate cell signaling and are potential targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860701453034

Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860701453034

The microenvironment of the tumour-host interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860701453034

Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860701453034

Cytotoxic targeting of F9 teratocarcinoma tumours with anti-ED-B fibronectin scFv antibody modified liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860701453034

Immunoliposomes for the targeted delivery of antitumor drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860701453034

Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860701453034

Tumor targeting using anti-her2 immunoliposomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860701453034

Future directions of liposome- and immunoliposome-based cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860701453034

Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860701453034

Cell-surface glycoproteins of human sarcomas: differential expression in normal and malignant tissues and cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860701453034

Generation of immunoliposomes using recombinant single-chain Fv fragments bound to Ni-NTA-liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860701453034

In vitro characterization of binding and stability of single-chain Fv Ni-NTA-liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860701453034

Vascular-targeting therapies for treatment of malignant disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860701453034

Targeting of immunoliposomes to endothelial cells using a single-chain Fv fragment directed against human endoglin (CD105).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10611860701453034

10.1080/10611860701453034

21 January 2018

Identifiers

DOI

1 reference

17 September 2017

1 reference